$FOMX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Foamix Pharmaceuticals Ltd..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Foamix Pharmaceuticals Ltd.. Get notifications about new insider transactions in Foamix Pharmaceuticals Ltd. for free.

Page:   < prev 1 2

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 06 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS4.0568275146,409146.5 K to 146.4 K (-0.05 %)
Dec 04 2018FOMXFoamix Pharmaceuti ...Wiley Matthew T.Chief Commercial Of ...Option ExerciseA4.06100,000406,000100,000
Dec 04 2018FOMXFoamix Pharmaceuti ...Wiley Matthew T.Chief Commercial Of ...GrantA0.0050,000050,0000 to 50 K
Nov 20 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS3.905,03619,640146,477151.5 K to 146.5 K (-3.32 %)
Nov 20 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatorySellS3.903,37513,16338,41441.8 K to 38.4 K (-8.08 %)
Nov 13 2018FOMXFoamix Pharmaceuti ...Stuart IainSVP R&DSellS4.586833,12833,60234.3 K to 33.6 K (-1.99 %)
Nov 13 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS4.582,0629,444151,513153.6 K to 151.5 K (-1.34 %)
Oct 02 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatorySellS5.812341,36041,78942 K to 41.8 K (-0.56 %)
Oct 02 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentSellS5.8114282512,44212.6 K to 12.4 K (-1.13 %)
Sep 06 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.6767380154,176154.2 K to 154.2 K (-0.04 %)
Aug 09 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.688,23846,792154,243162.5 K to 154.2 K (-5.07 %)
Aug 09 2018FOMXFoamix Pharmaceuti ...Stuart IainSVP R&DSellS5.682,71515,42134,28537 K to 34.3 K (-7.34 %)
Jul 13 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorOption ExerciseM0.001,61600
Jul 13 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorBuyM0.001,616012,97411.4 K to 13 K (+14.23 %)
Jul 03 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.106023,070162,481163.1 K to 162.5 K (-0.37 %)
Jul 03 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentSellS5.1014272412,58412.7 K to 12.6 K (-1.12 %)
Jun 04 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.2667352163,083163.2 K to 163.1 K (-0.04 %)
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorOption ExerciseX5.046,22431,3690
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorOption ExerciseX5.046,22431,3690
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorSellS5.096,16431,3696,50812.7 K to 6.5 K (-48.64 %)
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorSellS5.096,16431,3696,50812.7 K to 6.5 K (-48.64 %)
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorBuyX5.046,22431,36912,6726.4 K to 12.7 K (+96.53 %)
May 31 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorBuyX5.046,22431,36912,6726.4 K to 12.7 K (+96.53 %)
May 10 2018FOMXFoamix Pharmaceuti ...KAZANCHYAN ANNADirectorGrantA0.0014,829027,76012.9 K to 27.8 K (+114.68 %)
May 10 2018FOMXFoamix Pharmaceuti ...Bright RexDirectorOption ExerciseA5.0624,947126,23224,947
May 10 2018FOMXFoamix Pharmaceuti ...Hirsch StanleyDirectorOption ExerciseA5.0249,766249,82549,766
May 10 2018FOMXFoamix Pharmaceuti ...RIGEL DARRELL SDirectorOption ExerciseA5.0624,947126,23224,947
May 10 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOOption ExerciseA5.0670,187355,14670,187
May 10 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOGrantA0.0023,3960163,150186.5 K to 163.2 K (-12.54 %)
May 10 2018FOMXFoamix Pharmaceuti ...STERN STANLEYDirectorOption ExerciseA5.0624,947126,23224,947
May 10 2018FOMXFoamix Pharmaceuti ...Schwartz AharonDirectorOption ExerciseA5.0224,883124,91324,883
May 10 2018FOMXFoamix Pharmaceuti ...Megiddo DaliaDirectorOption ExerciseA5.0224,883124,91324,883
Apr 04 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatorySellS5.082341,18942,25742.5 K to 42.3 K (-0.55 %)
Apr 04 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentSellS5.0814272112,72612.9 K to 12.7 K (-1.10 %)
Apr 04 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.086023,058139,754140.4 K to 139.8 K (-0.43 %)
Mar 06 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentSellS6.148175,01612,86813.7 K to 12.9 K (-5.97 %)
Mar 05 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOSellS5.9566393140,356140.4 K to 140.4 K (-0.05 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP Intellectual Pro ...Option ExerciseA6.4015,00096,00015,000
Feb 28 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP Intellectual Pro ...GrantA0.005,000024,98020 K to 25 K (+25.03 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...Option ExerciseA6.4015,00096,00015,000
Feb 28 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...GrantA0.005,000024,98020 K to 25 K (+25.03 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...Option ExerciseA6.4035,093224,59535,093
Feb 28 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...GrantA0.0011,698092,37980.7 K to 92.4 K (+14.50 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Stuart IainSVP R&DOption ExerciseA6.3530,000190,50030,000
Feb 28 2018FOMXFoamix Pharmaceuti ...Stuart IainSVP R&DGrantA0.0010,000037,00027 K to 37 K (+37.04 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatoryOption ExerciseA6.3522,500142,87522,500
Feb 28 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatoryGrantA0.007,500042,49135 K to 42.5 K (+21.43 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...Option ExerciseA6.4015,00096,00015,000
Feb 28 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...GrantA0.005,000032,30027.3 K to 32.3 K (+18.32 %)
Feb 28 2018FOMXFoamix Pharmaceuti ...Harsch MutyaGeneral Counsel and ...Option ExerciseA6.3550,000317,50050,000
Feb 28 2018FOMXFoamix Pharmaceuti ...Harsch MutyaGeneral Counsel and ...GrantA0.0025,000025,0000 to 25 K
Feb 28 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentOption ExerciseA6.3526,250166,68826,250
Feb 28 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentGrantA0.008,750013,6854.9 K to 13.7 K (+177.30 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatoryOption ExerciseM0.002,28800
Jan 24 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatoryPayment of ExerciseF5.989245,52634,99135.9 K to 35 K (-2.57 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Howard Alvin DVP RegulatoryBuyM0.002,288035,91533.6 K to 35.9 K (+6.80 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...Option ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...Option ExerciseM0.004,57500
Jan 24 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...BuyM0.00562027,30026.7 K to 27.3 K (+2.10 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hazot YohanVP Pharmaceutical D ...BuyM0.004,575027,30022.7 K to 27.3 K (+20.13 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPOption ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPOption ExerciseM0.002,74500
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPBuyM0.00562019,98019.4 K to 20 K (+2.89 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPBuyM0.002,745019,98017.2 K to 20 K (+15.93 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...Option ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...Option ExerciseM0.002,74500
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...BuyM0.00562019,98019.4 K to 20 K (+2.89 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...BuyM0.002,745019,98017.2 K to 20 K (+15.93 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...Option ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPOption ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...Option ExerciseM0.005,03200
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPOption ExerciseM0.002,74500
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...BuyM0.00562080,68180.1 K to 80.7 K (+0.70 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPBuyM0.00562019,98019.4 K to 20 K (+2.89 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...BuyM0.005,032080,68175.6 K to 80.7 K (+6.65 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Schuz DavidVP IPBuyM0.002,745019,98017.2 K to 20 K (+15.93 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentOption ExerciseM0.001,37200
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentPayment of ExerciseF5.985553,3194,9355.5 K to 4.9 K (-10.11 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...Option ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentBuyM0.001,37205,4904.1 K to 5.5 K (+33.32 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...Option ExerciseM0.002,74500
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOOption ExerciseM0.005,94800
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...BuyM0.00562019,98019.4 K to 20 K (+2.89 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOPayment of ExerciseF5.982,39714,334140,422142.8 K to 140.4 K (-1.68 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Shirvan MitchellVP Innovation & Dis ...BuyM0.002,745019,98017.2 K to 20 K (+15.93 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOBuyM0.005,9480142,819136.9 K to 142.8 K (+4.35 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...Option ExerciseM0.0056200
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...Option ExerciseM0.005,03200
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...BuyM0.00562080,68180.1 K to 80.7 K (+0.70 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Hadar IlanCFO & Country Manag ...BuyM0.005,032080,68175.6 K to 80.7 K (+6.65 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentOption ExerciseM0.001,37200
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentPayment of ExerciseF5.985553,3194,9355.5 K to 4.9 K (-10.11 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Elliott Russell P.VP Drug DevelopmentBuyM0.001,37205,4904.1 K to 5.5 K (+33.32 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOOption ExerciseM0.005,94800
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOPayment of ExerciseF5.982,39714,334140,422142.8 K to 140.4 K (-1.68 %)
Jan 24 2018FOMXFoamix Pharmaceuti ...Domzalski DavidCEOBuyM0.005,9480142,819136.9 K to 142.8 K (+4.35 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirOption ExerciseM0.001,12504,500
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirOption ExerciseM0.005,032015,098
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirBuyM0.001,125017,39616.3 K to 17.4 K (+6.91 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirBuyM0.005,032016,27111.2 K to 16.3 K (+44.77 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.335,00031,6592,717,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.055,00030,2272,722,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.105,00030,5202,727,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.175,00030,8502,732,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.585,00032,8822,737,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.685,00033,4112,742,7812.7 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.265,00031,3112,747,7812.8 M to 2.7 M (-0.18 %)
Jan 18 2018FOMXFoamix Pharmaceuti ...Eini MeirSellS6.185,00030,9032,752,7812.8 M to 2.8 M (-0.18 %)

Page:   < prev 1 2

Contact us | Follow us on Twitter